Confectionery Consumption Trends Among GLP-1 Users
People taking GLP-1 medications are still buying and enjoying chocolate and candy on a regular basis. Recent research from…
-
-
What to Expect from Eli Lilly’s Next Earnings Report?
Eli Lilly is currently leading the market in diabetes and weight-loss drugs. A huge chunk of the company’s money…
-
Novo Nordisk Sues Eli Lilly Over Unfair Advertising Claims
Novo Nordisk has filed a lawsuit against Eli Lilly, claiming the rival drugmaker is using misleading ads to market…
-
Could Weight-Loss Drugs Be Curing Our Alcohol Cravings?
It turns out that semaglutide, the active ingredient in popular GLP-1 drugs like Wegovy and Ozempic, does more than…
-
How GLP-1 Weight-Loss Drugs Are Forcing Restaurants to Rethink Their Menus
Weight-loss drugs like Ozempic and Wegovy aren’t just changing waistlines, they are changing how Americans eat out. According to…
-
GLP-1 Medications and Your Teeth: What You Need to Know
GLP-1 medications work wonders for weight loss and managing type 2 diabetes. However, many people don’t realize these popular…
-
Burger King Adjusts Its Menu Strategy as GLP-1 Drug Use Reshapes Fast Food Demand
Burger King’s leaders are getting ready for a big, long-term shift in how people eat and they think GLP-1…
-
Weight Loss Drugs for Cats? Scientists Are Testing It
Could the same drugs helping people lose weight soon help overweight cats too? Two biotech companies are trying to…
-
Viking Therapeutics: Is This GLP-1 Contender Worth Watching?
The GLP-1 drug class has become one of the hottest areas in pharma right now. Viking Therapeutics is one…
-
Stopping GLP-1 Drugs May Raise Mental Health Risks in Type 2 Diabetes Patients
New research shows that people who stop taking GLP-1 receptor agonist drugs may face a higher risk of mental…
